hit counter
AstraZeneca PLC (AZN) Stock News Sentiment & Price - Sentifly
AZN - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



AstraZeneca PLC (AZN)

United Kingdom
Drug Manufacturers - Major
NYSE
AZN Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
AZN Latest news
The Motley Fool
Positive
Can AstraZeneca's COVID Antibody Therapy Win Against Regeneron and Eli Lilly?
16 hours ago

AstraZeneca's therapy could have at least one major advantage.

The Motley Fool
Positive
2 COVID Stocks I'd Consider Instead of Moderna
2021-10-21 10:00

Moderna has likely peaked. There are much safer growth stocks to buy right now.

Proactive Investors
Positive
AstraZeneca 'top pick' in pharma sector as JP Morgan predicts big growth ahead
2021-10-21 08:56

AstraZeneca PLC is the best bet in the pharma sector according to analysts at JP Morgan and even after a recent share price recovery there is still lots of value to be had, says the US bank. The pharma's medium-term growth prospects are yet to be fully reflected in the Anglo-Swedish group's valuation, said the bank in a note.

Benzinga
Negative
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
2021-10-20 13:27

AstraZeneca Plc (NASDAQ: AZN) has paused an active Phase 1 trial of AZD5991, a direct inhibitor of MCL-1, citing a potential safety issue. Two years ago, the FDA hit Amgen Inc (NASDAQ: AMGN) with a clinical hold on its MCL-1 inhibitor AMG 397 following signs of cardiac toxicity.

Business Wire
Neutral
AstraZeneca Announces Winners and Recognizes Oncology Change Makers in Third Annual Cancer Community Awards
2021-10-20 09:00

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca, in partnership with Scientific American Custom Media, today announced the winners of the third annual Cancer Community Awards (or C2 Awards). A part of the AstraZeneca YOUR Cancer program, the C2 Awards celebrate diverse individuals and organizations creating meaningful change in the lives of people with cancer and their loved ones across five unique categories. This year, a new Catalyst for Equity Award category was introduced to recognize those

The Motley Fool
Positive
Could This Beaten-Down Biotech Stock Be the Next Buyout Target?
2021-10-20 06:25

This gene-therapy specialist may need some help turning things around.

The Motley Fool
Positive
These 2 Nasdaq Biotechs Are Making Huge Premarket Moves Monday
2021-10-18 08:44

The Nasdaq looks poised to open slightly lower after a strong week.

Market Watch
Neutral
Pfizer and AstraZeneca vaccines were effective as prior infection, U.K. study finds
2021-10-18 05:14

Two doses of either the vaccine made by Pfizer PFE, -0.43% and BioNTech [s:bntx] or Oxford-AstraZeneca AZN, +0.92% vaccines provided a similar level of protection to prior natural infection when the Delta variant was dominant, the U.K. Office of National Statistics said Monday. Vaccination significantly reduced the risk of people testing positive during both the Alpha-dominant period and the Delta-dominant period, but effectiveness was reduced in the Delta-dominant period compared with the Alpha-dominant period.

The Motley Fool
Neutral
The Motley Fool
Positive
The Smartest Stocks to Buy With $200 Right Now
2021-10-15 05:51

A relatively small amount of money invested in great businesses can generate sizable returns over the long run.

Loading more news...